KMT2C not only may act as a tumor suppressor in leukemias and T-cell lymphomas,75, 76but it is also implicated in bladder, breast, colorectal, endometrial, gastric, head and neck, lung, and liver cancer, and in medulloblastoma.108. This evidence concerns the gene KMT2C and liver cancer.